Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats

Simple item page
dc.contributor.authorAkinlolu, A. A.
dc.contributor.authorAmeen, M. O.
dc.contributor.authorOyewopo, A. O.
dc.contributor.authorKadir, R. E.
dc.contributor.authorAhialaka, O.
dc.contributor.authorTijani, S.
dc.contributor.authorOgungbesan, O.
dc.contributor.authorBebeyi, R.
dc.contributor.authorAdebayo, S.
dc.contributor.authorAmoo, T.
dc.contributor.authorAbdulazeez, M.
dc.date.accessioned2022-11-10T09:24:33Z
dc.date.available2022-11-10T09:24:33Z
dc.date.issued2021-07
dc.description.abstractObjectives: Lead poisoning accounts for about 0.6% of global burden of disease. Lead-induced toxicity is through confinement of oxidative stress in affected organs. We evaluated the effects of MLF1 (extracted from Morinda lucida leaves) and AMF1 (extracted from Annona muricata leaves) on lipid peroxidation and immunomodulations of Melatonin, tumor necrosis factor-alpha (TNF-α), and p53 proteins in lead acetate (LA)-induced toxicity in rats. Methods: Sixty adult female rats were randomly divided into 12 groups (n = 5). Groups 1 and 2 received physiological saline and 100 mg/kg bodyweight of LA, respectively, for 5 weeks. Groups 3–6 received 100 mg/kg bodyweight LA for 2 weeks, followed by treatments with 7.5 and 15 mg/kg bodyweight of MLF1, and 7.5 and 10 mg/kg bodyweight of AMF1, respectively, for 3 weeks. Groups 7–10 received 7.5 and 15 mg/kg bodyweight of MLF1, 7.5 and 10 mg/kg bodyweight of AMF1, respectively, for 5 weeks. Groups 11–12 received co-administrations of 100 mg/kg bodyweight LA with 15 mg/kg bodyweight MLF1 and 10 mg/kg bodyweight of AMF1, respectively, for 5 weeks. Drugs and extracts were administered orally. Consequently, liver histopathology (Hematoxylin and Eosin), sera Melatonin, and TNF-α (enzyme-linked immunosorbent assay [ELISA]) levels were evaluated. Malondialdehyde (MDA) (thiobarbituric acid assay) and p53 (ELISA) levels were evaluated in liver homogenates. Data were statistically analyzed (P ≤ 0.05). Results: Results showed normal liver histology in all Groups. Statistical analyses showed significant (P ≤ 0.05) and non-significant decreased levels (P ≥ 0.05) of MDA, TNF-α and p53 in Groups 3-12, compared with Group 2. Furthermore, results showed significant (P ≤ 0.05) and non-significant increased Melatonin levels (P ≥ 0.05) in Groups 4–12 compared with Group 2. Conclusion: This study confirmed that MLF1 and AMF1 confer a degree of antioxidant, anticancer and hepato-protetive potentials against LA-induced toxicity in rats.en_US
dc.identifier.issn1658-3639
dc.identifier.urihttps://uilspace.unilorin.edu.ng/handle/20.500.12484/7877
dc.language.isoenen_US
dc.publisherQassim Universityen_US
dc.subjectMorinda lucidaen_US
dc.subjectAnnona muricataen_US
dc.subjectLeaden_US
dc.subjectlipid peroxidationen_US
dc.subjectMelatoninen_US
dc.subjecttumor necrosis factor-alphaen_US
dc.subjectp53en_US
dc.titleAnticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in ratsen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2021_Int. J. Health Sci._15(4)-20 – 28_Akinlolu, et al._ Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and .pdf
Size:
2.18 MB
Format:
Adobe Portable Document Format
Description:
Main Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections